ask="N/A"
ask_size="N/A"
average_daily_volume="43952"
bid="N/A"
bid_size="N/A"
book_value="5.83"
change="-0.35"
change_from_200_day_moving_average="1.10"
change_from_50_day_moving_average="-2.66"
change_from_52_week_high="-5.96"
change_From_52_week_low="10.38"
change_in_percent="-1.69%"
close="20.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.14"
ex_dividend_date="N/A"
float_shares="6898000"
high="21.80"
high_52_weeks="26.36"
last_trade_date="1/9/2017"
last_trade_price="20.40"
last_trade_size="1146"
last_trade_time="4:00pm"
low="20.09"
low_52_weeks="10.02"
market_capitalization="340.97M"
moving_average_200_day="19.30"
moving_average_50_day="23.06"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="20.52"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+5.68%"
percent_change_from_50_day_moving_average="-11.53%"
percent_change_from_52_week_high="-22.61%"
percent_change_from_52_week_low="+103.59%"
previous_close="20.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.56"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="4.64"
stock_exchange="NGM"
symbol="PTGX"
volume="73512"
weeks_range_52="10.02 - 26.36"
